|
New York
|
|
001-33861
|
|
11-2153962
|
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
2929 California Street, Torrance, CA
|
|
90503
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule l4a-12 under the Exchange Act (17 CFR 240.l4a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.01 per share
|
MPAA
|
The Nasdaq Global Select Market
|
|
Item 2.02.
|
Results of Operations and Financial Condition
|
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
|
Press Release, dated February 10, 2020
|
|
MOTORCAR PARTS OF AMERICA, INC.
|
||
|
|
|
|
|
Date: February 10, 2020
|
/s/ David Lee
|
|
|
|
David Lee
|
|
|
|
Chief Financial Officer
|
|
![]() |
| • |
Non-cash expenses of $3.7 million, including a write-down of $2.4 million associated with the quarterly revaluation for cores on customers’ shelves, and $1.3 million of amortization related to the premium for core buy backs.
|
| • |
Transition costs of $2.1 million associated with the move into the company’s new facilities in Mexico to support the growth in sales.
|
|
Three Months Ended
December 31,
|
Nine Months Ended
December 31,
|
|||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
Net sales
|
$
|
125,574,000
|
$
|
124,113,000
|
$
|
385,096,000
|
$
|
343,720,000
|
||||||||
|
Cost of goods sold
|
97,913,000
|
102,952,000
|
303,279,000
|
280,496,000
|
||||||||||||
|
Gross profit
|
27,661,000
|
21,161,000
|
81,817,000
|
63,224,000
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
General and administrative
|
10,618,000
|
12,331,000
|
36,903,000
|
33,419,000
|
||||||||||||
|
Sales and marketing
|
5,623,000
|
5,149,000
|
15,990,000
|
14,078,000
|
||||||||||||
|
Research and development
|
2,174,000
|
2,054,000
|
6,694,000
|
5,574,000
|
||||||||||||
|
Total operating expenses
|
18,415,000
|
19,534,000
|
59,587,000
|
53,071,000
|
||||||||||||
|
Operating income
|
9,246,000
|
1,627,000
|
22,230,000
|
10,153,000
|
||||||||||||
|
Interest expense, net
|
6,879,000
|
5,764,000
|
19,575,000
|
16,538,000
|
||||||||||||
|
Income (loss) before income tax expense (benefit)
|
2,367,000
|
(4,137,000
|
)
|
2,655,000
|
(6,385,000
|
)
|
||||||||||
|
Income tax expense (benefit)
|
1,502,000
|
(1,035,000
|
)
|
1,752,000
|
(1,301,000
|
)
|
||||||||||
|
Net income (loss)
|
$
|
865,000
|
$
|
(3,102,000
|
)
|
$
|
903,000
|
$
|
(5,084,000
|
)
|
||||||
|
Basic net income (loss) per share
|
$
|
0.05
|
$
|
(0.16
|
)
|
$
|
0.05
|
$
|
(0.27
|
)
|
||||||
|
Diluted net income (loss) per share
|
$
|
0.04
|
$
|
(0.16
|
)
|
$
|
0.05
|
$
|
(0.27
|
)
|
||||||
|
Weighted average number of shares outstanding:
|
||||||||||||||||
|
Basic
|
18,961,517
|
18,810,702
|
18,895,893
|
18,861,617
|
||||||||||||
|
Diluted
|
19,305,805
|
18,810,702
|
19,263,114
|
18,861,617
|
||||||||||||
|
December 31, 2019
|
March 31, 2019
|
||||||||
|
ASSETS
|
(Unaudited)
|
||||||||
|
Current assets:
|
|||||||||
|
Cash and cash equivalents
|
$
|
9,458,000
|
$
|
9,911,000
|
|||||
|
Short-term investments
|
2,382,000
|
3,273,000
|
|||||||
|
Accounts receivable — net
|
52,930,000
|
56,015,000
|
|||||||
|
Inventory— net
|
256,482,000
|
233,726,000
|
|||||||
|
Inventory unreturned
|
8,266,000
|
8,469,000
|
|||||||
|
Contract assets
|
22,616,000
|
22,183,000
|
|||||||
|
Income tax receivable
|
10,952,000
|
10,009,000
|
|||||||
|
Prepaid expenses and other current assets
|
10,332,000
|
9,296,000
|
|||||||
|
Total current assets
|
373,418,000
|
352,882,000
|
|||||||
|
Plant and equipment — net
|
43,314,000
|
35,151,000
|
|||||||
|
Operating lease assets
|
65,652,000
|
-
|
|||||||
|
Long-term deferred income taxes
|
8,722,000
|
9,746,000
|
|||||||
|
Long-term contract assets
|
224,569,000
|
221,876,000
|
|||||||
|
Goodwill
|
3,205,000
|
3,205,000
|
|||||||
|
Intangible assets — net
|
7,183,000
|
8,431,000
|
|||||||
|
Other assets
|
679,000
|
1,071,000
|
|||||||
|
TOTAL ASSETS
|
$
|
726,742,000
|
$
|
632,362,000
|
|||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|||||||||
|
Current liabilities:
|
|||||||||
|
Accounts payable
|
$
|
79,820,000
|
$
|
92,461,000
|
|||||
|
Accrued liabilities
|
17,008,000
|
14,604,000
|
|||||||
|
Customer finished goods returns accrual
|
25,223,000
|
22,615,000
|
|||||||
|
Contract liabilities
|
32,953,000
|
30,599,000
|
|||||||
|
Revolving loan
|
130,000,000
|
110,400,000
|
|||||||
|
Other current liabilities
|
4,651,000
|
4,990,000
|
|||||||
|
Operating lease liabilities
|
4,991,000
|
-
|
|||||||
|
Current portion of term loan
|
3,678,000
|
3,685,000
|
|||||||
|
Total current liabilities
|
298,324,000
|
279,354,000
|
|||||||
|
Term loan, less current portion
|
21,380,000
|
24,187,000
|
|||||||
|
Long-term contract liabilities
|
55,476,000
|
40,889,000
|
|||||||
|
Long-term deferred income taxes
|
302,000
|
257,000
|
|||||||
|
Long-term operating lease liabilities
|
61,805,000
|
-
|
|||||||
|
Other liabilities
|
5,129,000
|
7,920,000
|
|||||||
|
Total liabilities
|
442,416,000
|
352,607,000
|
|||||||
|
Commitments and contingencies
|
|||||||||
|
Shareholders’ equity:
|
|||||||||
|
Preferred stock; par value $.01 per share, 5,000,000 shares authorized; none issued
|
-
|
-
|
|||||||
|
Series A junior participating preferred stock; par value $.01 per share, 20,000 shares authorized; none issued
|
-
|
-
|
|||||||
|
Common stock; par value $.01 per share, 50,000,000 shares authorized; 18,965,030 and 18,817,400 shares issued and outstanding at December 31, 2019 and March 31, 2019, respectively
|
190,000
|
188,000
|
|||||||
|
Additional paid-in capital
|
217,530,000
|
215,047,000
|
|||||||
|
Retained earnings
|
72,310,000
|
71,407,000
|
|||||||
|
Accumulated other comprehensive loss
|
(5,704,000
|
)
|
(6,887,000
|
)
|
|||||
|
Total shareholders’ equity
|
284,326,000
|
279,755,000
|
|||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
726,742,000
|
$
|
632,362,000
|
|||||
|
Reconciliation of Non-GAAP Financial Measures
|
Exhibit 1
|
|
Three Months Ended December 31,
|
Nine Months Ended December 31,
|
|||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
GAAP Results:
|
||||||||||||||||
|
Net sales
|
$
|
125,574,000
|
$
|
124,113,000
|
$
|
385,096,000
|
$
|
343,720,000
|
||||||||
|
Net income (loss)
|
865,000
|
(3,102,000
|
)
|
903,000
|
(5,084,000
|
)
|
||||||||||
|
Income (loss) per share (EPS)
|
0.04
|
(0.16
|
)
|
0.05
|
(0.27
|
)
|
||||||||||
|
Gross margin
|
22.0
|
%
|
17.0
|
%
|
21.2
|
%
|
18.4
|
%
|
||||||||
|
Non-GAAP Adjusted Results:
|
||||||||||||||||
|
Non-GAAP adjusted net sales
|
$
|
127,677,000
|
$
|
119,630,000
|
$
|
387,670,000
|
$
|
343,592,000
|
||||||||
|
Non-GAAP adjusted net income
|
5,467,000
|
6,683,000
|
20,143,000
|
21,240,000
|
||||||||||||
|
Non-GAAP adjusted diluted income per share (EPS)
|
0.28
|
0.35
|
1.05
|
1.10
|
||||||||||||
|
Non-GAAP adjusted gross margin
|
26.9
|
%
|
25.8
|
%
|
26.7
|
%
|
26.1
|
%
|
||||||||
|
Non-GAAP adjusted EBITDA
|
$
|
16,486,000
|
$
|
16,190,000
|
$
|
53,233,000
|
$
|
48,961,000
|
||||||||
|
Reconciliation of Non-GAAP Financial Measures
|
Exhibit 2
|
|
Three Months Ended December 31,
|
Nine Months Ended December 31,
|
|||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
GAAP net sales
|
$
|
125,574,000
|
$
|
124,113,000
|
$
|
385,096,000
|
$
|
343,720,000
|
||||||||
|
Adjustments:
|
||||||||||||||||
|
Return and stock adjustment accruals related to new business and product line expansion
|
-
|
673,000
|
159,000
|
673,000
|
||||||||||||
|
Customer allowances related to new business
|
2,103,000
|
2,139,000
|
4,562,000
|
6,494,000
|
||||||||||||
|
Impact of sales price increases related to tariffs
|
-
|
(309,000
|
)
|
(2,280,000
|
)
|
(309,000
|
)
|
|||||||||
|
Core sales and cost in connection with a cancelled contract
|
-
|
(6,986,000
|
)
|
133,000
|
(6,986,000
|
)
|
||||||||||
|
Adjusted net sales
|
$
|
127,677,000
|
$
|
119,630,000
|
$
|
387,670,000
|
$
|
343,592,000
|
||||||||
|
Reconciliation of Non-GAAP Financial Measures
|
Exhibit 3
|
|
Three Months Ended December 31,
|
||||||||||||||||
|
2019
|
2018
|
|||||||||||||||
|
|
$ |
Per Diluted
Share
|
|
$ |
Per Diluted
Share
|
|||||||||||
|
GAAP net income (loss)
|
$
|
865,000
|
$
|
0.04
|
$
|
(3,102,000
|
)
|
$
|
(0.16
|
)
|
||||||
|
Adjustments:
|
||||||||||||||||
|
Net sales
|
||||||||||||||||
|
Return and stock adjustment accruals related to new business and product line expansion
|
-
|
-
|
673,000
|
0.04
|
||||||||||||
|
Customer allowances related to new business
|
2,103,000
|
0.11
|
2,139,000
|
0.11
|
||||||||||||
|
Impact of sales price increases related to tariffs
|
-
|
-
|
(309,000
|
)
|
(0.02
|
)
|
||||||||||
|
Core sales and cost in connection with a cancelled contract
|
-
|
-
|
(6,986,000
|
)
|
(0.36
|
)
|
||||||||||
|
Cost of goods sold
|
||||||||||||||||
|
New product line start-up and ramp-up costs, and transition expenses
|
2,148,000
|
0.11
|
2,078,000
|
0.11
|
||||||||||||
|
Revaluation - cores on customers’ shelves
|
2,395,000
|
0.12
|
2,619,000
|
0.14
|
||||||||||||
|
Cost of customer allowances and stock adjustment accruals related to new business and product line expansion
|
-
|
-
|
(51,000
|
)
|
(0.00
|
)
|
||||||||||
|
Tariff costs paid for products sold before price increases were effective
|
-
|
-
|
1,835,000
|
0.10
|
||||||||||||
|
Cost of goods sold for cores recorded in connection with a cancelled contract
|
-
|
-
|
7,750,000
|
0.40
|
||||||||||||
|
Operating expenses
|
||||||||||||||||
|
Acquisition, financing, transition, severance, new business, earn-out accruals from acquisitions, restatement-related fees and other costs
|
977,000
|
0.05
|
1,410,000
|
0.07
|
||||||||||||
|
Share-based compensation expenses
|
1,071,000
|
0.06
|
1,030,000
|
0.05
|
||||||||||||
|
Mark-to-market losses (gains)
|
(3,772,000
|
)
|
(0.20
|
)
|
860,000
|
0.04
|
||||||||||
|
Tax effected (a)
|
(320,000
|
)
|
(0.02
|
)
|
(3,263,000
|
)
|
(0.17
|
)
|
||||||||
|
Adjusted net income
|
$
|
5,467,000
|
$
|
0.28
|
$
|
6,683,000
|
$
|
0.35
|
||||||||
|
Reconciliation of Non-GAAP Financial Measures
|
Exhibit 4
|
|
Nine Months Ended December 31,
|
||||||||||||||||
|
2019
|
2018
|
|||||||||||||||
|
|
$ |
Per Diluted
Share
|
|
$ |
Per Diluted
Share
|
|||||||||||
|
GAAP net income (loss)
|
$
|
903,000
|
$
|
0.05
|
$
|
(5,084,000
|
)
|
$
|
(0.27
|
)
|
||||||
|
Adjustments:
|
||||||||||||||||
|
Net sales
|
||||||||||||||||
|
Return and stock adjustment accruals related to new business and product line expansion
|
159,000
|
0.01
|
673,000
|
0.03
|
||||||||||||
|
Customer allowances related to new business
|
4,562,000
|
0.24
|
6,494,000
|
0.34
|
||||||||||||
|
Impact of sales price increases related to tariffs
|
(2,280,000
|
)
|
(0.12
|
)
|
(309,000
|
)
|
(0.02
|
)
|
||||||||
|
Core sales and cost in connection with a cancelled contract
|
133,000
|
0.01
|
(6,986,000
|
)
|
(0.36
|
)
|
||||||||||
|
Cost of goods sold
|
||||||||||||||||
|
New product line start-up and ramp-up costs, and transition expenses
|
5,829,000
|
0.30
|
5,666,000
|
0.29
|
||||||||||||
|
Revaluation - cores on customers’ shelves
|
9,867,000
|
0.51
|
11,466,000
|
0.60
|
||||||||||||
|
Cost of customer allowances and stock adjustment accruals related to new business and product line expansion
|
(59,000
|
)
|
(0.00
|
)
|
(51,000
|
)
|
(0.00
|
)
|
||||||||
|
Tariff costs paid for products sold before price increases were effective
|
3,347,000
|
0.17
|
1,835,000
|
0.10
|
||||||||||||
|
Cost of goods sold for cores recorded in connection with a cancelled contract
|
-
|
-
|
7,750,000
|
0.40
|
||||||||||||
|
Operating expenses
|
||||||||||||||||
|
Acquisition, financing, transition, severance, new business, earn-out accruals from acquisitions, restatement-related fees and other costs
|
2,040,000
|
0.11
|
3,085,000
|
0.16
|
||||||||||||
|
Share-based compensation expenses
|
3,112,000
|
0.16
|
3,151,000
|
0.16
|
||||||||||||
|
Mark-to-market losses (gains)
|
(2,507,000
|
)
|
(0.13
|
)
|
1,628,000
|
0.08
|
||||||||||
|
Interest
|
||||||||||||||||
|
Write-off of debt issuance costs
|
-
|
303,000
|
0.02
|
|||||||||||||
|
Tax effected (a)
|
(4,963,000
|
)
|
(0.26
|
)
|
(8,381,000
|
)
|
(0.44
|
)
|
||||||||
|
Adjusted net income
|
$
|
20,143,000
|
$
|
1.05
|
$
|
21,240,000
|
$
|
1.10
|
||||||||
|
Reconciliation of Non-GAAP Financial Measures
|
Exhibit 5
|
|
Three Months Ended December 31,
|
||||||||||||||||
|
2019
|
2018
|
|||||||||||||||
|
|
$ |
Gross Margin
|
|
$ |
Gross Margin
|
|||||||||||
|
GAAP gross profit
|
$
|
27,661,000
|
22.0
|
%
|
$
|
21,161,000
|
17.0
|
%
|
||||||||
|
Adjustments:
|
||||||||||||||||
|
Net sales
|
||||||||||||||||
|
Return and stock adjustment accruals related to new business and product line expansion
|
-
|
673,000
|
||||||||||||||
|
Customer allowances related to new business
|
2,103,000
|
2,139,000
|
||||||||||||||
|
Impact of sales price increases related to tariffs
|
-
|
(309,000
|
)
|
|||||||||||||
|
Core sales and cost in connection with a cancelled contract
|
-
|
(6,986,000
|
)
|
|||||||||||||
|
Cost of goods sold
|
||||||||||||||||
|
New product line start-up and ramp-up costs, and transition expenses
|
2,148,000
|
2,078,000
|
||||||||||||||
|
Revaluation - cores on customers’ shelves
|
2,395,000
|
2,619,000
|
||||||||||||||
|
Cost of customer allowances and stock adjustment accruals related to new business and product line expansion
|
-
|
(51,000
|
)
|
|||||||||||||
|
Tariff costs paid for products sold before price increases were effective
|
-
|
1,835,000
|
||||||||||||||
|
Cost of goods sold for cores recorded in connection with a cancelled contract
|
-
|
7,750,000
|
||||||||||||||
|
Total adjustments
|
6,646,000
|
4.9
|
%
|
9,748,000
|
8.8
|
%
|
||||||||||
|
Adjusted gross profit
|
$
|
34,307,000
|
26.9
|
%
|
$
|
30,909,000
|
25.8
|
%
|
||||||||
|
Reconciliation of Non-GAAP Financial Measures
|
Exhibit 6
|
|
Nine Months Ended December 31,
|
||||||||||||||||
|
2019
|
2018
|
|||||||||||||||
|
|
$ |
Gross Margin
|
|
$ |
Gross Margin
|
|||||||||||
|
GAAP gross profit
|
$
|
81,817,000
|
21.2
|
%
|
$
|
63,224,000
|
18.4
|
%
|
||||||||
|
Adjustments:
|
||||||||||||||||
|
Net sales
|
||||||||||||||||
|
Return and stock adjustment accruals related to new business and product line expansion
|
159,000
|
673,000
|
||||||||||||||
|
Customer allowances related to new business
|
4,562,000
|
6,494,000
|
||||||||||||||
|
Impact of sales price increases related to tariffs
|
(2,280,000
|
)
|
(309,000
|
)
|
||||||||||||
|
Core sales and cost in connection with a cancelled contract
|
133,000
|
(6,986,000
|
)
|
|||||||||||||
|
Cost of goods sold
|
||||||||||||||||
|
New product line start-up and ramp-up costs, and transition expenses
|
5,829,000
|
5,666,000
|
||||||||||||||
|
Revaluation - cores on customers’ shelves
|
9,867,000
|
11,466,000
|
||||||||||||||
|
Cost of customer allowances and stock adjustment accruals related to new business and product line expansion
|
(59,000
|
)
|
(51,000
|
)
|
||||||||||||
|
Tariff costs paid for products sold before price increases were effective
|
3,347,000
|
1,835,000
|
||||||||||||||
|
Cost of goods sold for cores recorded in connection with a cancelled contract
|
-
|
7,750,000
|
||||||||||||||
|
Total adjustments
|
21,558,000
|
5.5
|
%
|
26,538,000
|
7.7
|
%
|
||||||||||
|
Adjusted gross profit
|
$
|
103,375,000
|
26.7
|
%
|
$
|
89,762,000
|
26.1
|
%
|
||||||||
|
Reconciliation of Non-GAAP Financial Measures
|
Exhibit 7
|
|
Three Months Ended December 31,
|
Nine Months Ended December 31,
|
|||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
GAAP net income (loss)
|
$
|
865,000
|
$
|
(3,102,000
|
)
|
$
|
903,000
|
$
|
(5,084,000
|
)
|
||||||
|
Interest expense, net
|
6,879,000
|
5,764,000
|
19,575,000
|
16,538,000
|
||||||||||||
|
Income tax expense (benefit)
|
1,502,000
|
(1,035,000
|
)
|
1,752,000
|
(1,301,000
|
)
|
||||||||||
|
Depreciation and amortization
|
2,400,000
|
1,715,000
|
7,019,000
|
4,933,000
|
||||||||||||
|
EBITDA
|
$
|
11,646,000
|
$
|
3,342,000
|
$
|
29,249,000
|
$
|
15,086,000
|
||||||||
|
Adjustments:
|
||||||||||||||||
|
Net sales
|
||||||||||||||||
|
Return and stock adjustment accruals related to new business and product line expansion
|
-
|
673,000
|
159,000
|
673,000
|
||||||||||||
|
Customer allowances related to new business
|
2,103,000
|
2,139,000
|
4,562,000
|
6,494,000
|
||||||||||||
|
Impact of sales price increases related to tariffs
|
-
|
(309,000
|
)
|
(2,280,000
|
)
|
(309,000
|
)
|
|||||||||
|
Core sales and cost in connection with a cancelled contract
|
-
|
(6,986,000
|
)
|
133,000
|
(6,986,000
|
)
|
||||||||||
|
Cost of goods sold
|
||||||||||||||||
|
New product line start-up and ramp-up costs, and transition expenses (a)
|
2,096,000
|
1,969,000
|
5,703,000
|
5,399,000
|
||||||||||||
|
Revaluation - cores on customers’ shelves
|
2,395,000
|
2,619,000
|
9,867,000
|
11,466,000
|
||||||||||||
|
Cost of customer allowances and stock adjustment accruals related to new business and product line expansion
|
-
|
(51,000
|
)
|
(59,000
|
)
|
(51,000
|
)
|
|||||||||
|
Tariff costs paid for products sold before price increases were effective
|
-
|
1,835,000
|
3,347,000
|
1,835,000
|
||||||||||||
|
Cost of goods sold for cores recorded in connection with a cancelled contract
|
-
|
7,750,000
|
-
|
7,750,000
|
||||||||||||
|
Operating expenses
|
||||||||||||||||
|
Acquisition, financing, transition (a), severance, new business, earn-out accruals from acquisitions, restatement-related fees and other costs
|
947,000
|
1,319,000
|
1,947,000
|
2,825,000
|
||||||||||||
|
Share-based compensation expenses
|
1,071,000
|
1,030,000
|
3,112,000
|
3,151,000
|
||||||||||||
|
Mark-to-market losses (gains)
|
(3,772,000
|
)
|
860,000
|
(2,507,000
|
)
|
1,628,000
|
||||||||||
|
Adjusted EBITDA
|
$
|
16,486,000
|
$
|
16,190,000
|
$
|
53,233,000
|
$
|
48,961,000
|
||||||||